PL2013166T3 - N-karbamoilometylo-4(R)-fenylo-2-pirolidynon, sposób jego wytwarzania i zastosowanie farmaceutyczne - Google Patents

N-karbamoilometylo-4(R)-fenylo-2-pirolidynon, sposób jego wytwarzania i zastosowanie farmaceutyczne

Info

Publication number
PL2013166T3
PL2013166T3 PL07726915T PL07726915T PL2013166T3 PL 2013166 T3 PL2013166 T3 PL 2013166T3 PL 07726915 T PL07726915 T PL 07726915T PL 07726915 T PL07726915 T PL 07726915T PL 2013166 T3 PL2013166 T3 PL 2013166T3
Authority
PL
Poland
Prior art keywords
pyrrolidinone
phenyl
carbamoylmethyl
preparation
pharmaceutical use
Prior art date
Application number
PL07726915T
Other languages
English (en)
Inventor
Grigory Veinberg
Maksim Vorona
Liga Zvejniece
Aleksandrs Chernobrovijs
Ivars Kalvinsh
Ligita Karina
Maija Dambrova
Original Assignee
Akciju Sabiedriba Olainfarm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akciju Sabiedriba Olainfarm filed Critical Akciju Sabiedriba Olainfarm
Publication of PL2013166T3 publication Critical patent/PL2013166T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
    • C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
PL07726915T 2006-03-16 2007-03-15 N-karbamoilometylo-4(R)-fenylo-2-pirolidynon, sposób jego wytwarzania i zastosowanie farmaceutyczne PL2013166T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
LVP-06-45A LV13630B (en) 2006-03-16 2006-03-16 Method of preparation and use of pharmaceutically active n-carbamoylmethyl-4(r)-phenyl-2-pyrrolidinone
EP07726915A EP2013166B1 (en) 2006-03-16 2007-03-15 N-carbamoylmethyl-4(r)-phenyl-2-pyrrolidinone, method of its preparation and pharmaceutical use
PCT/EP2007/052424 WO2007104780A2 (en) 2006-03-16 2007-03-15 N- carbamoylmethyl- 4- (r) -phenyl-2-pyrr0lidin0ne, method of its preparation and pharmaceutical use

Publications (1)

Publication Number Publication Date
PL2013166T3 true PL2013166T3 (pl) 2010-08-31

Family

ID=38461010

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07726915T PL2013166T3 (pl) 2006-03-16 2007-03-15 N-karbamoilometylo-4(R)-fenylo-2-pirolidynon, sposób jego wytwarzania i zastosowanie farmaceutyczne

Country Status (21)

Country Link
US (2) US9102615B2 (pl)
EP (1) EP2013166B1 (pl)
CN (1) CN101448786A (pl)
AT (1) ATE460396T1 (pl)
CA (1) CA2647206C (pl)
CY (1) CY1110170T1 (pl)
DE (1) DE602007005244D1 (pl)
DK (1) DK2013166T3 (pl)
EA (1) EA014668B1 (pl)
EE (1) EE05536B1 (pl)
ES (1) ES2342024T3 (pl)
GE (1) GEP20104915B (pl)
HR (1) HRP20090524C1 (pl)
LT (1) LT5589B (pl)
LV (1) LV13630B (pl)
ME (1) ME01192B (pl)
PL (1) PL2013166T3 (pl)
PT (1) PT2013166E (pl)
SI (1) SI2013166T1 (pl)
UA (1) UA96440C2 (pl)
WO (1) WO2007104780A2 (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LV14346B (lv) * 2009-11-05 2011-07-20 Grindeks, A/S 2-(4-Fenil-5-metil-2-oksopirolidin-1-il)-acetamīda 4R,5S-enantiomērs ar nootropo aktivitāti
RU2013141257A (ru) * 2011-03-11 2015-04-20 Гриндекс 4r, 5r-энантиомер 2-(5-метил-2-оксо-4-фенилпирролидин-1-ил) ацетамида с ноотропной активностью
RU2480214C1 (ru) * 2011-09-22 2013-04-27 Валентина Ивановна Ахапкина Состав, обладающий модуляторной активностью с соразмерным влиянием, фармацевтическая субстанция (варианты), применение фармацевтической субстанции, фармацевтическая и парафармацевтическая композиция (варианты), способ получения фармацевтических составов
CN104350063B (zh) 2012-05-08 2018-01-05 尼科斯眼药公司 疏水性治疗剂的制剂、其制备方法及应用
TW201408293A (zh) 2012-07-05 2014-03-01 Merz Pharma Gmbh & Co Kgaa (r)-苯基披喇瑟盪於治療疾病相關疲勞之用途
TW201408294A (zh) 2012-07-05 2014-03-01 Merz Pharma Gmbh & Co Kgaa (r)-苯基披喇瑟盪於治療帕金森氏症之用除
LV15003B (lv) * 2013-10-22 2015-08-20 Latvijas Organiskās Sintēzes Institūts Farmaceitiska kompozīcija ķermeņa masas pieauguma kontrolei
LV15015B (lv) 2013-12-13 2015-12-20 Olainfarm, A/S 3-karboksi-4-(R)-fenilpirolidin-2-ona sāls un tā pielietošana
LV15016B (lv) * 2013-12-18 2016-01-20 Olainfarm, A/S N-karbamoilmetil-4(R)-fenil-2-pirolidinona polimorfās formas
EP2891491A1 (en) 2014-01-03 2015-07-08 Merz Pharma GmbH & Co. KGaA Use of (r)-phenylpiracetam for the treatment of sleep disorders
LV15072B (lv) 2014-05-14 2016-09-20 Olainfarm, A/S Farmaceitiska kompozīcija izmantošanai patoloģiska stāvokļa, kam raksturīga paaugstināta iNOS gēna ekspresija, profilaksei un ārstēšanai
EP3127539A1 (en) 2015-08-03 2017-02-08 Latvian Institute Of Organic Synthesis Use of 2-(5s-methyl-2-oxo-4r-phenyl-pyrrolidin-1-yl)-acetamide in the treatment of seizures
WO2024049236A1 (ko) * 2022-08-31 2024-03-07 고려대학교 산학협력단 키랄 감마 락탐 유도체 또는 이의 약학적으로 허용가능한 염 및 이의 제조방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0004297D0 (en) * 2000-02-23 2000-04-12 Ucb Sa 2-oxo-1 pyrrolidine derivatives process for preparing them and their uses
RU2232578C1 (ru) * 2003-04-10 2004-07-20 Ахапкина Валентина Ивановна Вещество, обладающее антидепрессивной активностью
RU2289404C1 (ru) * 2005-04-06 2006-12-20 ГОУ ВПО "Московский государственный медико-стоматологический университет Министерства здравоохранения РФ" Способ премедикации у пациентов со средним уровнем психоэмоционального напряжения при амбулаторных стоматологических вмешательствах

Also Published As

Publication number Publication date
EP2013166A2 (en) 2009-01-14
US9382203B2 (en) 2016-07-05
EA014668B1 (ru) 2010-12-30
PT2013166E (pt) 2010-06-09
HRP20090524C1 (hr) 2017-03-10
US9102615B2 (en) 2015-08-11
DK2013166T3 (da) 2010-07-05
GEP20104915B (en) 2010-03-10
CN101448786A (zh) 2009-06-03
DE602007005244D1 (de) 2010-04-22
SI2013166T1 (sl) 2010-07-30
EA200801978A1 (ru) 2009-04-28
US20150216846A1 (en) 2015-08-06
LV13630B (en) 2007-12-20
HRPK20090524B3 (hr) 2012-12-31
WO2007104780A3 (en) 2007-11-29
ME01192B (me) 2012-12-20
ES2342024T3 (es) 2010-06-30
LT5589B (lt) 2009-08-25
UA96440C2 (ru) 2011-11-10
EE05536B1 (et) 2012-04-16
CY1110170T1 (el) 2015-01-14
WO2007104780A2 (en) 2007-09-20
CA2647206A1 (en) 2007-09-20
US20100022784A1 (en) 2010-01-28
HRP20090524A2 (hr) 2009-12-31
CA2647206C (en) 2011-09-27
ATE460396T1 (de) 2010-03-15
LT2008075A (en) 2009-06-25
EP2013166B1 (en) 2010-03-10
EE200800063A (et) 2008-12-15

Similar Documents

Publication Publication Date Title
PL2013166T3 (pl) N-karbamoilometylo-4(R)-fenylo-2-pirolidynon, sposób jego wytwarzania i zastosowanie farmaceutyczne
IL180286A0 (en) Novel cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
TWI365866B (en) Amide derivatives, process for preparation thereof and use thereof as insecticide
MY154909A (en) Novel thiophene derivatives
ZA200700709B (en) Substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
TW200637522A (en) Skin treatment articles and methods
MX2010004576A (es) Derivados de pirimidina novedosos.
MY148723A (en) Use of pinolenic acid for the treatment of obesity
ZA200805247B (en) Quinazoline derivatives, process for their preparation and their use as anti-cancer agents
MY149705A (en) Pyridino-pyridinone derivatives, preparation therof, and therapeutic use thereof
SI2057153T1 (sl) (3-ril-piperazin-1-il) derivati 6,7-dialkoksikuinazolin, 6,7-dialkoksiftalazin in 6,7-dialkoksiizokuinolin
SG148192A1 (en) Azabenzimidazole derivatives, their manufacture and use as anti-cancer agents
IL192442A0 (en) Novel cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
PT2185561E (pt) Derivados de 1,2,3,4-tetra-hidropirrolo(1,2-a)pirazina-6- carboxamidas e de 2,3,4,5-tetra-hidropirrolo(1,2-a)-diazepina-7- carboxamidas, sua preparação e sua aplicação em terapia
WO2009024838A3 (en) Impression and model components
GB2443377A (en) Anti-malarial composition comprising artesunate and lumefantrine
GEP20115158B (en) Use of ivabradine for obtaining medicaments intended for the treatment of endothelial dysfunction
IL197769A (en) The history of morphine, medicinal preparations containing them and their use in the preparation of pain medication
IL190675A0 (en) Tricyclic lactam derivatives, their manufacture and use as pharmaceutical agents
UA87524C2 (ru) Бензотиазолсодержащая композиция с макроголглицеридом и ее использование
ZA201005397B (en) 17-(1'-propenyl)-17-3'-oxidoestra-4-en-3-one derivative,use thereof,and medicament containing said derivative
AU311455S (en) Cycle mudguard
AU311456S (en) Cycle mudguard
UA42611U (uk) Засіб для лікування та профілактики урологічних захворювань у формі гелю для перорального застосування
UA11522U (uk) Спосіб профілактики гнійно-запальних ускладнень пологових травм промежини